Stevanato Group S.p.A. (STVN) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Stevanato Group S.p.A. Revenue Highlights


Latest Revenue (Y)

$1.06B

Latest Revenue (Q)

$237.38M

Main Geography (Y)

Europe Middle East And Africa

Stevanato Group S.p.A. Revenue by Period


Stevanato Group S.p.A. Revenue by Year

DateRevenueChange
2023-12-31$1.06B8.08%
2022-12-31$983.70M16.57%
2021-12-31$843.90M27.47%
2020-12-31$662.04M23.39%
2019-12-31$536.54M-

Stevanato Group S.p.A. generated $1.06B in revenue during NA 2023, up 8.08% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Stevanato Group S.p.A. Revenue by Quarter

DateRevenueChange
2024-03-31$237.38M-24.02%
2023-12-31$312.41M15.11%
2023-09-30$271.40M6.31%
2023-06-30$255.30M7.27%
2023-03-31$237.99M-18.52%
2022-12-31$292.10M19.10%
2022-09-30$245.26M4.70%
2022-06-30$234.25M10.46%
2022-03-31$212.07M-8.82%
2021-12-31$232.60M8.42%
2021-09-30$214.53M5.18%
2021-06-30$203.96M5.76%
2021-03-31$192.85M-6.72%
2020-12-31$206.74M31.63%
2020-09-30$157.06M-2.94%
2020-06-30$161.81M18.60%
2020-03-31$136.43M-

Stevanato Group S.p.A. generated $237.38M in revenue during Q1 2024, up -24.02% compared to the previous quarter, and up 81.27% compared to the same period a year ago.

Stevanato Group S.p.A. Revenue Breakdown


Stevanato Group S.p.A. Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22
South America$30.87M$40.00M
Asia Pacific$102.90M$117.75M
Europe Middle East And Africa$634.05M$705.95M
North America$317.54M$294.71M

Stevanato Group S.p.A.'s latest annual revenue breakdown by geography, as of Dec 23: Europe Middle East And Africa (58.42%), North America (29.26%), Asia Pacific (9.48%), and South America (2.84%).

Stevanato Group S.p.A. Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
ALCAlcon$10.09B$2.46B
RMDResMed$4.69B$1.20B
XRAYDENTSPLY SIRONA$3.96B$984.00M
COOCooper Companies$3.59B$1.00B
ATRAptarGroup$3.49B$910.06M
TFXTeleflex$2.97B$749.69M
WSTWest Pharmaceutical Services$2.95B$702.00M
NVSTEnvista$2.57B$623.60M
ICUIICU Medical$2.26B$596.46M
HAEHaemonetics$1.31B$336.17M
MMSIMerit Medical Systems$1.26B$338.00M
STVNStevanato Group S.p.A.$1.06B$237.38M
ATRCAtriCure$399.25M$116.27M
ANGOAngioDynamics$303.91M$75.18M
AKYAAkoya Biosciences$96.63M$23.16M

STVN Revenue FAQ


Stevanato Group S.p.A.'s yearly revenue for 2023 was $1.06B, representing an increase of 8.08% compared to 2022. The company's yearly revenue for 2022 was $983.7M, representing an increase of 16.57% compared to 2021. STVN's yearly revenue for 2021 was $843.9M, representing an increase of 27.47% compared to 2020.

Stevanato Group S.p.A.'s quarterly revenue for Q1 2024 was $237.38M, a -24.02% decrease from the previous quarter (Q4 2023), and a -0.26% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $312.41M, a 15.11% increase from the previous quarter (Q3 2023), and a 6.95% increase year-over-year (Q4 2022). STVN's quarterly revenue for Q3 2023 was $271.4M, a 6.31% increase from the previous quarter (Q2 2023), and a 10.66% increase year-over-year (Q3 2022).

Stevanato Group S.p.A.'s revenue growth rate for the last 3 years (2021-2023) was 25.98%, and for the last 5 years (2019-2023) was 98.15%.